股票 
板块 
用户 
资讯 This October, the global pharmaceutical industry will once again turn its focus to Milan, Italy. Newland Pharma has confirmed its participation in CPHI Worldwide 2026 at Fiera Milano, Booth H3K98. We will present our specialty APIs, intermediates, and tailored CMO/CDMO services, and look forward to engaging with global partners on supply chain collaboration, process development, and reliable delivery.
参展CPHI Worldwide，对接全球医药供应链
Participating in CPHI Worldwide to connect with the global pharmaceutical supply chain.
据展会主办方公开信息，CPHI Worldwide是制药原料领域规模较大的国际展会之一。2026年展会落地米兰新国际会展中心（Fiera Milano），展出体量约16万平方米，预计约2500家展商同台、逾4.2万名专业买家到场，中国参展企业约650家。
对于希望对接欧美主流采购体系的企业而言，这里不仅是一个展台，更是一个与全球供应链直接交流的平台。新天地药业此次参展，也正是希望把我们在原料药与中间体领域积累的工艺能力、质量体系和交付经验，放到全球客户的视线中。
According to the organizer, CPHI Worldwide is one of the largest trade events for pharmaceutical ingredients. The 2026 edition will be held at Fiera Milano, with an exhibition area of approximately 160,000 square meters, bringing together around 2,500 exhibitors, over 42,000 trade visitors, and roughly 650 Chinese suppliers.
For manufacturers seeking to connect with mainstream Western procurement systems, the event provides a platform for direct engagement with global supply chain partners. Newland Pharma is pleased to bring its accumulated capabilities in APIs and intermediates to this global stage.
技术立身，持续提升质量体系
Anchored in technology, continuously enhancing quality systems.
新天地药业长期专注医药中间体、原料药与制剂的研发与生产，把“质量稳定、工艺可控”视为合作的重要基础。公司拥有现代化生产装置和完善的全过程质量追溯体系，部分特色原料药已取得CEP等国际认证，面向不同注册市场提供合规、可持续的供应。
在米兰现场，我们将重点呈现：特色原料药、医药中间体、CMO/CDMO定制化服务。从工艺路线开发、放大生产，到质量管控与稳定交付，我们依托在原料药及中间体领域积累的研发与生产经验，帮助客户管控供应风险，让合作从“能做”走向“能稳定做”。
Newland Pharma has long focused on the R&D and manufacturing of pharmaceutical intermediates, APIs, and finished formulations, and regards “consistent quality and controllable processes” as an important foundation for cooperation. The company has modern production facilities and a comprehensive end-to-end quality traceability system. Some specialty APIs have obtained CEP and other international certifications, and the company provides compliant and sustainable supply for different registration markets.
At CPHI Milan, we will highlight: Specialty APIs; intermediates; Tailored CDMO/CMO services. From initial route development and process scale-up through to analytical quality control and commercial delivery, we support clients in managing supply chain risk based on our accumulated experience in R&D and manufacturing of APIs and intermediates.
期待相逢，共话合作
Looking forward to connecting in Milan and advancing our partnership.
如果您正在寻找稳定可靠的原料药与中间体伙伴，或想就某个具体项目深入交流，欢迎来H3K98。我们的技术与商务团队届时都在现场，可以围绕以下方向进行面对面沟通：
产品规格与注册市场；
工艺开发与放大生产；
质量体系与审计安排；
产能规划与交付节奏；
CMO/CDMO项目合作。
我们不只交换名片，更希望把工艺、质量、法规和交付放在一张桌子上，和您一起把项目聊清楚。
Whether you are seeking a trusted API and intermediate manufacturing partner or discussing a specific project, we invite you to visit Booth H3K98. Our technical and commercial teams will be on-site to discuss:
Product specifications and registration markets;
Process development and scale-up;
Quality systems and audit arrangements;
Production capacity and delivery schedules;
CDMO/CMO collaboration.
展会信息 / Exhibition Information
展会名称：2026 年世界制药原料展览会（意大利米兰）
Event: CPHI Worldwide 2026 – Milan, Italy
展会时间：2026 年 10 月 6 日 — 10 月 8 日
Dates: 6 – 8 October 2026
展会地点：意大利米兰新国际会展中心（Fiera Milano，Rho）
Venue: Fiera Milano, Rho, Milan, Italy
展位号：新天地药业 H3K98
Booth No.: Newland Pharma H3K98
声明：本公众号所有信息仅供参考，不构成投资建议，最终以公司指定的巨潮资讯网和中国证监会指定的其他网站和报刊为准。请广大投资者注意投资风险。展会数据来源于主办方公开信息，仅供参考，最终以主办方确认数据为准。
评论 (0)